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Solid dosage forms such as tablets, granules or capsules represent over 80% of all pharmaceutical products. 
Modern pharmaceutical formulations are designed so as to release the active pharmaceutical ingredient (API) at 
a well-defined and reproducible rate. Two main classes of dosage forms can be distinguished: rapid release 
formulations (which are designed to disintegrate rapidly and dissolve the API within the shortest possible time), 
and sustained release formulations (which are designed to release the API gradually over a prolonged period of 
time, typically 24 hours). In both cases, the effective transport properties of the drug carrier (granule, tablet) play 
a crucial role. The wetting and imbibition of gastric juices into the porous structure of the tablet determines the 
time-scale over which the individual drug particles will be contacted with the dissolution medium, which the 
diffusion of the dissolve drug substance trough the tablet structure determines the release rate. Pharmaceutical 
formulations typically contain not only the API particles but also several auxiliary components (excipients) such 
as fillers, disintegrants, binders, controlled release polymers, lubricants, surfactants, etc. The porous structure is 
formed hierarchically, starting with the blending of the initial powders with given particle size distributions, 
followed by dry or wet agglomeration into granules, which are then compressed into the final tablets. The 
understanding of a relationship between the material properties of the formulation, the parameters of the 
manufacturing process, and the effective transport properties (water permeability and drug diffusivity) of the final 
pharmaceutical product is therefore crucial when developing new solid dosage forms. 
 
In this contribution, we will present our recent progress on the combination of 3D imaging methods (MRI, micro 
CT), spectroscopic analytical methods (UV/Vis spectrophotometry) and mathematical modeling to evaluate the 
effective transport properties of pharmaceutical granules and tablets. By systematically changing the 
manufacturing process parameters (granulation conditions, tabletting pressure) and the formulation composition 
(ratio of API and excipients), we have prepared a series of structutres with systematically varying drug release 
profiles. The rate-limiting step was identified in each case, and three limiting regimes were found: drug release 
limited by water transport into the tablet, drug release limited by intrinsic dissolution kinetics of the API, and drug 
release limited by the diffusion of API from the tablet. The knowledge of these limiting regimes then and their 
dependence on the formulation and processing parameters then allows rational choices to be made when 
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